Gilead Sciences, Inc. (GILD)
USD 90.69
(-2.27%)
USD 90.69
(-2.27%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 5.66 Billion USD | 23.37% |
| 2022 | 4.59 Billion USD | -26.23% |
| 2021 | 6.22 Billion USD | 6894.38% |
| 2020 | 89 Million USD | -98.35% |
| 2019 | 5.38 Billion USD | -1.26% |
| 2018 | 5.45 Billion USD | 17.87% |
| 2017 | 4.62 Billion USD | -65.72% |
| 2016 | 13.5 Billion USD | -25.44% |
| 2015 | 18.1 Billion USD | 49.64% |
| 2014 | 12.1 Billion USD | 293.55% |
| 2013 | 3.07 Billion USD | 18.65% |
| 2012 | 2.59 Billion USD | -7.56% |
| 2011 | 2.8 Billion USD | -3.36% |
| 2010 | 2.9 Billion USD | 10.07% |
| 2009 | 2.63 Billion USD | 31.06% |
| 2008 | 2.01 Billion USD | 24.51% |
| 2007 | 1.61 Billion USD | 235.74% |
| 2006 | -1.18 Billion USD | -246.2% |
| 2005 | 813.91 Million USD | 81.12% |
| 2004 | 449.37 Million USD | 724.1% |
| 2003 | -72 Million USD | -199.87% |
| 2002 | 72.09 Million USD | 37.93% |
| 2001 | 52.27 Million USD | 192.07% |
| 2000 | -56.77 Million USD | 14.62% |
| 1999 | -66.5 Million USD | -18.54% |
| 1998 | -56.1 Million USD | -100.36% |
| 1997 | -28 Million USD | -29.03% |
| 1996 | -21.7 Million USD | 20.8% |
| 1995 | -27.4 Million USD | -6.61% |
| 1994 | -25.7 Million USD | 0.0% |
| 1992 | -14.1 Million USD | -213.33% |
| 1991 | -4.5 Million USD | -12.5% |
| 1990 | -4 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -4.17 Billion USD | -391.81% |
| 2024 Q2 | 1.61 Billion USD | 138.71% |
| 2023 Q4 | 1.42 Billion USD | -34.45% |
| 2023 Q1 | 1.01 Billion USD | -38.41% |
| 2023 FY | 5.66 Billion USD | 23.37% |
| 2023 Q2 | 1.04 Billion USD | 3.47% |
| 2023 Q3 | 2.18 Billion USD | 108.61% |
| 2022 Q3 | 1.78 Billion USD | 56.38% |
| 2022 Q2 | 1.14 Billion USD | 9433.33% |
| 2022 FY | 4.59 Billion USD | -26.23% |
| 2022 Q4 | 1.64 Billion USD | -8.33% |
| 2022 Q1 | 12 Million USD | -96.86% |
| 2021 FY | 6.22 Billion USD | 6894.38% |
| 2021 Q1 | 1.72 Billion USD | 11.48% |
| 2021 Q2 | 1.52 Billion USD | -11.97% |
| 2021 Q3 | 2.59 Billion USD | 70.3% |
| 2021 Q4 | 382 Million USD | -85.26% |
| 2020 Q1 | 1.55 Billion USD | -42.47% |
| 2020 Q2 | -3.33 Billion USD | -315.28% |
| 2020 Q4 | 1.55 Billion USD | 330.83% |
| 2020 FY | 89 Million USD | -98.35% |
| 2020 Q3 | 360 Million USD | 110.78% |
| 2019 Q4 | 2.69 Billion USD | 331.42% |
| 2019 Q1 | 1.97 Billion USD | 65733.33% |
| 2019 FY | 5.38 Billion USD | -1.26% |
| 2019 Q3 | -1.16 Billion USD | -161.97% |
| 2019 Q2 | 1.88 Billion USD | -4.81% |
| 2018 Q4 | 3 Million USD | -99.86% |
| 2018 FY | 5.45 Billion USD | 17.87% |
| 2018 Q3 | 2.09 Billion USD | 15.41% |
| 2018 Q2 | 1.81 Billion USD | 18.14% |
| 2018 Q1 | 1.53 Billion USD | 139.79% |
| 2017 Q4 | -3.86 Billion USD | -242.2% |
| 2017 Q1 | 2.7 Billion USD | -13.06% |
| 2017 FY | 4.62 Billion USD | -65.72% |
| 2017 Q2 | 3.07 Billion USD | 13.73% |
| 2017 Q3 | 2.71 Billion USD | -11.55% |
| 2016 Q2 | 3.49 Billion USD | -1.93% |
| 2016 FY | 13.5 Billion USD | -25.44% |
| 2016 Q1 | 3.56 Billion USD | -23.85% |
| 2016 Q3 | 3.33 Billion USD | -4.78% |
| 2016 Q4 | 3.1 Billion USD | -6.67% |
| 2015 Q4 | 4.68 Billion USD | 1.8% |
| 2015 Q3 | 4.6 Billion USD | 2.4% |
| 2015 Q2 | 4.49 Billion USD | 3.67% |
| 2015 Q1 | 4.33 Billion USD | 24.27% |
| 2015 FY | 18.1 Billion USD | 49.64% |
| 2014 FY | 12.1 Billion USD | 293.55% |
| 2014 Q4 | 3.48 Billion USD | 27.67% |
| 2014 Q3 | 2.73 Billion USD | -25.3% |
| 2014 Q1 | 2.22 Billion USD | 181.4% |
| 2014 Q2 | 3.65 Billion USD | 64.17% |
| 2013 Q3 | 788.6 Million USD | 2.07% |
| 2013 FY | 3.07 Billion USD | 18.65% |
| 2013 Q1 | 722.18 Million USD | -5.29% |
| 2013 Q2 | 772.6 Million USD | 6.98% |
| 2013 Q4 | 791.41 Million USD | 0.36% |
| 2012 FY | 2.59 Billion USD | -7.56% |
| 2012 Q4 | 762.54 Million USD | 12.88% |
| 2012 Q3 | 675.5 Million USD | -5.07% |
| 2012 Q2 | 711.56 Million USD | 61.0% |
| 2012 Q1 | 441.95 Million USD | -33.55% |
| 2011 FY | 2.8 Billion USD | -3.36% |
| 2011 Q4 | 665.14 Million USD | -10.25% |
| 2011 Q3 | 741.12 Million USD | -0.68% |
| 2011 Q2 | 746.22 Million USD | 14.6% |
| 2011 Q1 | 651.14 Million USD | 3.45% |
| 2010 Q2 | 712.06 Million USD | -16.71% |
| 2010 Q3 | 704.87 Million USD | -1.01% |
| 2010 FY | 2.9 Billion USD | 10.07% |
| 2010 Q4 | 629.41 Million USD | -10.71% |
| 2010 Q1 | 854.9 Million USD | 6.57% |
| 2009 FY | 2.63 Billion USD | 31.06% |
| 2009 Q2 | 571.39 Million USD | -3.01% |
| 2009 Q3 | 673.03 Million USD | 17.79% |
| 2009 Q4 | 802.21 Million USD | 19.19% |
| 2009 Q1 | 589.11 Million USD | 3.68% |
| 2008 Q4 | 568.19 Million USD | 12.74% |
| 2008 Q3 | 504 Million USD | 15.92% |
| 2008 Q2 | 434.78 Million USD | -10.96% |
| 2008 Q1 | 488.3 Million USD | 21.58% |
| 2008 FY | 2.01 Billion USD | 24.51% |
| 2007 Q3 | 398.31 Million USD | -2.36% |
| 2007 Q4 | 401.64 Million USD | 0.83% |
| 2007 Q2 | 407.93 Million USD | 0.13% |
| 2007 Q1 | 407.4 Million USD | 124.46% |
| 2007 FY | 1.61 Billion USD | 235.74% |
| 2006 FY | -1.18 Billion USD | -246.2% |
| 2006 Q2 | 265.15 Million USD | 0.93% |
| 2006 Q1 | 262.7 Million USD | -6.71% |
| 2006 Q3 | -52.16 Million USD | -119.67% |
| 2006 Q4 | -1.66 Billion USD | -3093.1% |
| 2005 Q1 | 157.11 Million USD | 42.51% |
| 2005 FY | 813.91 Million USD | 81.12% |
| 2005 Q4 | 281.6 Million USD | 57.12% |
| 2005 Q3 | 179.23 Million USD | -8.54% |
| 2005 Q2 | 195.96 Million USD | 24.73% |
| 2004 Q1 | 114.42 Million USD | -40.58% |
| 2004 Q3 | 113.24 Million USD | 1.6% |
| 2004 Q4 | 110.24 Million USD | -2.65% |
| 2004 Q2 | 111.45 Million USD | -2.59% |
| 2004 FY | 449.37 Million USD | 724.1% |
| 2003 Q1 | -438.05 Million USD | -1334.69% |
| 2003 Q4 | 192.58 Million USD | 163.47% |
| 2003 Q2 | 100.37 Million USD | 122.91% |
| 2003 Q3 | 73.09 Million USD | -27.17% |
| 2003 FY | -72 Million USD | -199.87% |
| 2002 Q4 | 35.47 Million USD | 70.93% |
| 2002 FY | 72.09 Million USD | 37.93% |
| 2002 Q2 | 19.71 Million USD | 611.97% |
| 2002 Q3 | 20.75 Million USD | 5.31% |
| 2002 Q1 | -3.85 Million USD | -102.93% |
| 2001 Q1 | -21.72 Million USD | 25.77% |
| 2001 Q3 | -25.19 Million USD | 22.2% |
| 2001 Q2 | -32.38 Million USD | -49.09% |
| 2001 FY | 52.27 Million USD | 192.07% |
| 2001 Q4 | 131.57 Million USD | 622.21% |
| 2000 Q1 | -5.76 Million USD | 35.99% |
| 2000 FY | -56.77 Million USD | 14.62% |
| 2000 Q2 | -4.18 Million USD | 27.34% |
| 2000 Q3 | -17.56 Million USD | -319.59% |
| 2000 Q4 | -29.26 Million USD | -66.62% |
| 1999 Q2 | -15 Million USD | 5.06% |
| 1999 Q3 | -30.4 Million USD | -102.67% |
| 1999 Q4 | -9 Million USD | 70.39% |
| 1999 FY | -66.5 Million USD | -18.54% |
| 1999 Q1 | -15.8 Million USD | 3.07% |
| 1998 Q3 | -17.6 Million USD | -18.92% |
| 1998 Q1 | -7.4 Million USD | 40.32% |
| 1998 Q2 | -14.8 Million USD | -100.0% |
| 1998 Q4 | -16.3 Million USD | 7.39% |
| 1998 FY | -56.1 Million USD | -100.36% |
| 1997 Q4 | -12.4 Million USD | -20.39% |
| 1997 Q2 | 2.7 Million USD | 134.18% |
| 1997 Q1 | -7.9 Million USD | 1.25% |
| 1997 FY | -28 Million USD | -29.03% |
| 1997 Q3 | -10.3 Million USD | -481.48% |
| 1996 Q3 | 9.3 Million USD | 176.23% |
| 1996 FY | -21.7 Million USD | 20.8% |
| 1996 Q4 | -8 Million USD | -186.02% |
| 1996 Q2 | -12.2 Million USD | -12.96% |
| 1996 Q1 | -10.8 Million USD | 0.0% |
| 1995 Q2 | -7.9 Million USD | 11.24% |
| 1995 Q3 | -8.4 Million USD | -6.33% |
| 1995 FY | -27.4 Million USD | -6.61% |
| 1995 Q1 | -8.9 Million USD | -8.54% |
| 1994 Q3 | -7 Million USD | 2.78% |
| 1994 Q4 | -8.2 Million USD | -17.14% |
| 1994 FY | -25.7 Million USD | 0.0% |
| 1994 Q1 | -8.4 Million USD | -25.37% |
| 1994 Q2 | -7.2 Million USD | 14.29% |
| 1993 Q4 | -6.7 Million USD | -15.52% |
| 1993 Q1 | -5.7 Million USD | -46.15% |
| 1993 Q2 | -4.8 Million USD | 15.79% |
| 1993 Q3 | -5.8 Million USD | -20.83% |
| 1992 FY | -14.1 Million USD | -213.33% |
| 1992 Q4 | -3.9 Million USD | -44.44% |
| 1992 Q3 | -2.7 Million USD | -50.0% |
| 1992 Q2 | -1.8 Million USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1991 Q1 | -1 Million USD | -11.11% |
| 1991 Q2 | - USD | 100.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1991 FY | -4.5 Million USD | -12.5% |
| 1990 Q3 | -1 Million USD | 0.0% |
| 1990 Q2 | -1 Million USD | 0.0% |
| 1990 Q4 | -900 Thousand USD | 10.0% |
| 1990 FY | -4 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Amgen Inc. | 6.71 Billion USD | 15.662% |
| AstraZeneca PLC | 5.95 Billion USD | 4.87% |
| Biogen Inc. | 1.16 Billion USD | -387.899% |
| MIRA Pharmaceuticals, Inc. | -11.98 Million USD | 47377.899% |
| Scilex Holding Company | -114.33 Million USD | 5054.912% |
| Scilex Holding Company | -114.33 Million USD | 5054.912% |